IL17A and prostate cancer: The enrichment pathways identified following KEGG analysis that contained the most core targets included prostate cancer, the HIF-1 signaling pathway, insulin resistance, the IL-17 signaling pathway, the PI3K-Akt signaling pathway, the TNF signaling pathway, and more (Figure S7B).